CN103768328A - Medicinal magnetic plaster for treating tumors - Google Patents
Medicinal magnetic plaster for treating tumors Download PDFInfo
- Publication number
- CN103768328A CN103768328A CN201410046681.5A CN201410046681A CN103768328A CN 103768328 A CN103768328 A CN 103768328A CN 201410046681 A CN201410046681 A CN 201410046681A CN 103768328 A CN103768328 A CN 103768328A
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- radix
- magnetic
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of medicines, and in particular relates to a medicinal magnetic plaster for treating tumors. The plaster comprises a medical adhesive tape, more than 20 traditional Chinese medicines, a medicinal magnetic layer made of a permanent magnet or magnetic powder, a protective layer and the like. The medicinal magnetic plaster has the effects of dredging collaterals, removing stasis, eliminating phlegm, promoting diuresis, removing toxicity to relieve pain, relieving and eliminating mass and the like to inhibit tumor growth, changing shapes of cancer cells, inducing apoptosis of tumor cells, gradually reducing tumors, eliminating inflammation of vascular wall, controlling transfer of pain signals, improving local micro-circulation, controlling spread and pain of medium or advanced cancer, and the like; the plaster can be divided in different magnetic field strength, different shapes and different specification models; when the plaster is used, the required specification model is selected, the protective layer is peeled off, the medicinal magnetic layer of the stagnation-eliminating plaster is directly adhered to the meridian skin, corresponding acupoint or the Shenque acupoint in a range of the focus area, and the plaster is fixed by the medical adhesive tape; different parts can be adhered by multiple plasters at the same time, and each plaster is used for 1-2 days.
Description
Technical field
The invention belongs to field of medical technology, particularly a kind of medicated magnetic plaster that is used for the treatment of tumor.
Background technology
As far back as 1997, oncotherapy association of the U.S. just to the world declare publicly " chemicotherapy treatment tumor is failed method; with perform the operation and chemicotherapy treatment cancer after; cancerous cell accelerates diffusion on the contrary; only have 0.5% can live through 5 years through the patient of chemicotherapy, but also be differentiated patient " report; The Chinese Central Television (CCTV) in 2013 has also reported that China is every year because chemical synthetic drug causes dead surprising numeral, so World Modern medical science is all being sought new Therapeutic Method.
Treatment of the prior art has following deficiency: 1. dangerous large in operation process, patient is very painful, perioperatively expense is high, sew up to form after cicatrix and form again new retardance, cause to relevant conduction place and shift, so can not solve the root problem that forms tumor pathogenesis; 2. the toxicity of medicine chemotherapy is very large, and enter after the blood and internal organs of Whole Body, not only have the peak valley phenomenon of medicine, cannot play the property of medicine effect of even persistence, when bringing the medicine source hurt to whole body, cause patient immune function to decline, and therapeutic effect is not ideal enough; 3. the effect for the treatment of by Chinese herbs tumor is slow, the power of patch Chinese medicine compatibility is poor, thus treatment tumor be all the time clinical in a thorny difficult problem.
Summary of the invention
The object of the invention is to make up deficiency of the prior art or blank, and provide that a kind of serious disease letter is controlled, inner disease outer treat take effect quick, easy to use, curative effect is determined, the medicated magnetic plaster that is used for the treatment of tumor that has no side effect.
The object of the invention is to realize by following technical approach: the medicated magnetic plaster that is used for the treatment of tumor, its feature one is made up of following 20 multidigit raw materials by weight portion: 20～50 parts of Radix Notoginseng, 20～50 parts of Sanguis Draxonis, 10～30 parts of Pheretimas, 20～50 parts of Eupolyphaga Seu Steleophagas, 20～50 parts of Radix Et Rhizoma Rhei, 20～50 parts of Radix Gentianae Macrophyllae, 30～50 parts of Rhizoma Corydalis, 20～50 parts of Borneolum Syntheticums, 20～30 parts of wild ginsengs, 10～30 parts of Scorpios, 20～50 parts of Scolopendras, 10～50 parts of Radix Pseudostellariaes, 10～50 parts of Olibanums, 20～50 parts, Flos Carthami, 10～50 parts of Myrrhas, 10～50 parts of Cortex Phellodendris, 10～30 parts of the Radix Aucklandiae, 30～50 parts of Rhizoma Cyperis, 30～50 parts of Oletum Trogopteroris, 10～50 parts of Radix Angelicae Sinensis, 20～30 parts of azones, 50～80 parts of magnetic powders, each 20～50 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add magnetic powder, after azone, be mixed with 1: 2～10 hot-fusible pressure-sensitive adhesive heating again, be positioned over and on transdermal skeleton magnetic material, make medicated magnetic plaster or medicated magnet analgesic ointment.
Its feature two is made up of following 20 multidigit raw materials by weight portion: 20～50 parts of Radix Notoginseng, 20～50 parts of Sanguis Draxonis, 10～30 parts of Pheretimas, 20～50 parts of Eupolyphaga Seu Steleophagas, 20～50 parts of Radix Et Rhizoma Rhei, 20～50 parts of Radix Gentianae Macrophyllae, 30～50 parts of Rhizoma Corydalis, 20～50 parts of Borneolum Syntheticums, 20～30 parts of wild ginsengs, 10～30 parts of Scorpios, 20～50 parts of Scolopendras, 10～50 parts of Radix Pseudostellariaes, 10～50 parts of Olibanums, 20～50 parts, Flos Carthami, 10～50 parts of Myrrhas, 10～50 parts of Cortex Phellodendris, 10～30 parts of the Radix Aucklandiae, 30～50 parts of Rhizoma Cyperis, 30～50 parts of Oletum Trogopteroris, 10～50 parts of Radix Angelicae Sinensis, 20～30 parts of azones, each 20～50 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add after azone, be mixed with 1: 2～10 hot-fusible pressure-sensitive adhesive heating again, be positioned over after making ointment table on transdermal framework material and stick on the permanent magnet that magnetic field intensity is 0.1～0.5T.
The present invention has following features and effect
1. simple in structure, easy to use: the present invention is the above 20 multidigit medicines by wine dipper or alcohol extraction, with the heating of 1: 2～10 hot-fusible pressure-sensitive adhesive be mixed, the composition such as permanent magnet or magnetic powder, medical adhesive tape, protective layer; Product of the present invention is that eliminate indigestion pastes, and is that eliminate indigestion is affixed on to the meridians of tumor focus or relevant acupuncture points on the human body, SHENQUE acupoint, and each different parts can paste use more, sticks 1～2 day at every turn.For suppress tumor growth, control diffusion and the pain of middle and terminal cancer and there is good effect.
2. effect feature uniqueness, effect are remarkable: the traditional Chinese medical science is thought: the formation of tumor is to cause that because of cold-evil, melancholy anger " stagnation of QI, blood stasis, expectorant are solidifying, the poly-result of keeping here at Local Shape materialize lump of poison; The pain of tumor is because blockage of meridian, qi stagnation hemagglutination, dyspepsia are depressed, damp-phlegm knot combinate form becomes the poly-reason of the dead blood poison of pertinacious phlegm; So should give: dredging collateral dissipating blood stasis, the dampness removing that eliminates the phlegm, the pain relieving of drawing out pus by applying a plaster to the affected part, the consumer product dredge stasis methods such as eliminating mass and relieving fullness removing food stagnancy, could control tumor growth and pain.
Radix Notoginseng in the present invention, Sanguis Draxonis, Olibanum, Scorpio can dredging collateral dissipating blood stasis, chase after poison draws out pus by applying a plaster to the affected part, again can eliminating mass and relieving fullness removing food stagnancy, and institute thinks monarch drug of the present invention; Be aided with Pheretima, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis, Scolopendra, Flos Carthami, Myrrha, Rhizoma Cyperi, the Radix Aucklandiae, Oletum Trogopterori etc. take dredge the meridian passage, blood circulation promoting and blood stasis dispelling, removing obstruction for relieving pain as ministerial drug; Eliminate the phlegm dampness removing, heat-clearing and toxic substances removing, anti-inflammatory analgetic as adjuvant drug take Radix Et Rhizoma Rhei, Cortex Phellodendri, black and white Semen Pharbitidis, Borneolum Syntheticum; With tonify deficiency righting, clearing away the hectic fever, expelling wind and removing dampness and blood relaxing muscles and tendons, coordinating the actions of various ingredients in a prescription such as Radix Angelicae Sinensis, Radix Gentianae Macrophyllae, wild ginseng, Radix Pseudostellariaes for making medicine.Wherein in side, the Olibanum, Scorpio, Pheretima, Eupolyphaga Seu Steleophaga, Scolopendra, Borneolum Syntheticum of compatibility etc. are away the medicine of string or causing resuscitation with aromatic drugs, can impel that efficacy of a drug rapid transdermal absorbs, through focus and chase after poison and draw out pus by applying a plaster to the affected part, with square medicine each other compatibility reach dredging collateral dissipating blood stasis, the growth of the inhibition tumor of the dampness removing that eliminates the phlegm, the pain relieving of drawing out pus by applying a plaster to the affected part, eliminating mass and relieving fullness removing food stagnancy, control the diffusion of middle and terminal cancer and the effect of pain.
Trade name of the present invention is that eliminate indigestion pastes, and after using 5 courses for the treatment of, clinical verification is as following table:
| Eliminate indigestion pastes | Case sum | Cure number | Effective number | Significant figure | Invalid number | Cure rate % | Total effective rate % |
| Breast carcinoma | 100 | 45 | 40 | 13 | 2 | 45％ | 98％ |
| Lymphatic cancer | 100 | 41 | 30 | 26 | 3 | 41％ | 97％ |
| Thyroid carcinoma | 100 | 50 | 41 | 9 | 0 | 50％ | 100％ |
| Pulmonary carcinoma | 100 | 48 | 35 | 26 | 1 | 48％ | 99％ |
| Hepatocarcinoma | 100 | 35 | 39 | 24 | 2 | 35％ | 98％ |
| Stomach, intestinal cancer | 100 | 23 | 42 | 31 | 4 | 23％ | 96％ |
Validation criteria: case sum adopts randomly draws method, sex half and half, 21～84 years old age, 51 years old mean age;
Diagnostic criteria: the VRS method that adopts CT, MRI, X-ray etc. to check and ratify with reference to WHO, is divided into three grades by pain intensity: I level: mild pain (sleep quality is unaffected); II level: moderate pain (sleep has been subject to ache influence); III level: severe pain < pain cannot be stood, with pale complexion etc.).
Criterion of therapeutical effect: adopt CT, MRI, X-ray etc. to check and criterion of therapeutical effect that national TCM on tumor Professional Committee cancer pain cooperative groups is formulated: (1) CR (alleviating completely): pain relief 91～IOO%; (2) AR (obviously alleviating): pain relief 61%～90%; (3) MR (partial rcsponse): pain relief 60～90%; (4) NR (invalid): relatively front with treatment, pain is unchanged;
Cure number: adopt CT, MRI, X-ray etc. to check foci disappearance and follow the trail of 3 months methods, obviously dwindling with contrast tumor or hydrops before and after method inspection, it is effective that total pain relief etc. are considered as; Pain is obviously alleviated, is alleviated or symptom improvement is considered as effectively.
Checking conclusion: eliminate indigestion pastes and uses after 3～5 courses for the treatment of, total effective rate, on average 98%, has absolutely proved the useful effect effect of eliminate indigestion subsides and the uniqueness that serious disease letter is controlled.
3. high safety: this product verifies through the pharmaceutical analysis institute of Bureau of Drugs Supervision:, sensitization rate non-stimulated to skin is 0; Do not find untoward reaction through clinical verification, fully to have confirmed its safety.
4. the scope of application is wide: eliminate indigestion pastes not only has the effect for the treatment of dredging collateral dissipating blood stasis, the dampness removing that eliminates the phlegm, the pain relieving of drawing out pus by applying a plaster to the affected part, eliminating mass and relieving fullness removing food stagnancy, inhibition tumor growth, the diffusion of control middle and terminal cancer, and has the effects such as treatment various inflammation, hydrops and analgesia.
The specific embodiment
Embodiment 1: formed by following 20 multidigit raw materials by weight portion: 30 parts of Radix Notoginseng, 30 parts of Sanguis Draxonis, 20 parts of Pheretimas, 30 parts of Eupolyphaga Seu Steleophagas, 30 parts of Radix Et Rhizoma Rhei, 30 parts of Radix Gentianae Macrophyllae, 30 parts of Rhizoma Corydalis, 30 parts of Borneolum Syntheticums, 20 parts of wild ginsengs, 20 parts of Scorpios, 30 parts of Scolopendras, 30 parts of Radix Pseudostellariaes, 30 parts of Olibanums, 30 parts, Flos Carthami, 30 parts of Myrrhas, 30 parts of Cortex Phellodendris, 20 parts of the Radix Aucklandiae, 30 parts of Rhizoma Cyperis, 30 parts of Oletum Trogopteroris, 30 parts of Radix Angelicae Sinensis, 20 parts of azones, 60 parts of magnetic powders, each 30 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add magnetic powder, after azone, be mixed with the hot-fusible pressure-sensitive adhesive heating of 1: 5 again, be positioned over and on transdermal skeleton magnetic material, make medicated magnetic plaster or medicated magnet analgesic ointment, add a cover medical adhesive tape and protective layer, packaging of aluminium foil bag and get final product,
Embodiment 2: formed by following raw materials by weight portion: 30 parts of Radix Notoginseng, 30 parts of Sanguis Draxonis, 20 parts of Pheretimas, 30 parts of Eupolyphaga Seu Steleophagas, 30 parts of Radix Et Rhizoma Rhei, 30 parts of Radix Gentianae Macrophyllae, 30 parts of Rhizoma Corydalis, 30 parts of Borneolum Syntheticums, 20 parts of wild ginsengs, 20 parts of Scorpios, 30 parts of Scolopendras, 30 parts of Radix Pseudostellariaes, 30 parts of Olibanums, 30 parts, Flos Carthami, 30 parts of Myrrhas, 30 parts of Cortex Phellodendris, 20 parts of the Radix Aucklandiae, 30 parts of Rhizoma Cyperis, 30 parts of Oletum Trogopteroris, 30 parts of Radix Angelicae Sinensis, 20 parts of azones, 60 parts of magnetic powders, each 30 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add after azone, be mixed with the hot-fusible pressure-sensitive adhesive heating of 1: 8 again, be positioned over after making ointment table or bar cloth plaster on transdermal framework material and stick on the permanent magnet that magnetic field intensity is 0.1～0.25T, add a cover medical adhesive tape and protective layer, packaging of aluminium foil bag and get final product.
Embodiment 3: formed by following raw materials by weight portion: 50 parts of Radix Notoginseng, 50 parts of Sanguis Draxonis, 30 parts of Pheretimas, 50 parts of Eupolyphaga Seu Steleophagas, 50 parts of Radix Et Rhizoma Rhei, 50 parts of Radix Gentianae Macrophyllae, 50 parts of Rhizoma Corydalis, 50 parts of Borneolum Syntheticums, 30 parts of wild ginsengs, 30 parts of Scorpios, 50 parts of Scolopendras, 50 parts of Radix Pseudostellariaes, 50 parts of Olibanums, 50 parts, Flos Carthami, 50 parts of Myrrhas, 50 parts of Cortex Phellodendris, 30 parts of the Radix Aucklandiae, 50 parts of Rhizoma Cyperis, 50 parts of Oletum Trogopteroris, 50 parts of Radix Angelicae Sinensis, 30 parts of azones, each 35 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add after azone, be mixed with the hot-fusible pressure-sensitive adhesive heating of 1: 3 again, be positioned over after making ointment table or bar cloth plaster on transdermal framework material and stick on the permanent magnet that magnetic field intensity is 0.25～0.5T, add a cover medical adhesive tape and protective layer, packaging of aluminium foil bag and get final product.
In actual use, can take the circumstances into consideration compatibility umber according to all ages and classes, different parts, the different state of an illness, make the medicated magnetic plaster that is used for the treatment of tumor of different size model.
Claims (2)
1. be used for the treatment of the medicated magnetic plaster of tumor, its feature one is made up of following 20 multidigit raw materials by weight portion: 20～50 parts of Radix Notoginseng, 20～50 parts of Sanguis Draxonis, 10～30 parts of Pheretimas, 20～50 parts of Eupolyphaga Seu Steleophagas, 20～50 parts of Radix Et Rhizoma Rhei, 20～50 parts of Radix Gentianae Macrophyllae, 30～50 parts of Rhizoma Corydalis, 20～50 parts of Borneolum Syntheticums, 20～30 parts of wild ginsengs, 10～30 parts of Scorpios, 20～50 parts of Scolopendras, 10～50 parts of Radix Pseudostellariaes, 10～50 parts of Olibanums, 20～50 parts, Flos Carthami, 10～50 parts of Myrrhas, 10～50 parts of Cortex Phellodendris, 10～30 parts of the Radix Aucklandiae, 30～50 parts of Rhizoma Cyperis, 30～50 parts of Oletum Trogopteroris, 10～50 parts of Radix Angelicae Sinensis, each 20～50 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add 20～30 parts of azones, after 50～80 parts of magnetic powders, be mixed with 1: 2～10 hot-fusible pressure-sensitive adhesive heating again, be positioned over and on transdermal skeleton magnetic material, make medicated magnetic plaster or medicated magnet analgesic ointment,
2. be used for the treatment of the medicated magnetic plaster of tumor, its feature two is made up of following 20 multidigit raw materials by weight portion: 20～50 parts of Radix Notoginseng, 20～50 parts of Sanguis Draxonis, 10～30 parts of Pheretimas, 20～50 parts of Eupolyphaga Seu Steleophagas, 20～50 parts of Radix Et Rhizoma Rhei, 20～50 parts of Radix Gentianae Macrophyllae, 30～50 parts of Rhizoma Corydalis, 20～50 parts of Borneolum Syntheticums, 20～30 parts of wild ginsengs, 10～30 parts of Scorpios, 20～50 parts of Scolopendras, 10～50 parts of Radix Pseudostellariaes, 10～50 parts of Olibanums, 20～50 parts, Flos Carthami, 10～50 parts of Myrrhas, 10～50 parts of Cortex Phellodendris, 10～30 parts of the Radix Aucklandiae, 30～50 parts of Rhizoma Cyperis, 30～50 parts of Oletum Trogopteroris, 10～50 parts of Radix Angelicae Sinensis, 20～30 parts of azones, each 20～50 parts of black and white Semen Pharbitidis, above-mentioned medical material mixed powder is broken into coarse powder, by wine or ethanol lifting manipulation, be concentrated into thick paste, add after azone, be mixed with 1: 2～10 hot-fusible pressure-sensitive adhesive heating again, be positioned over after making ointment table on transdermal framework material and stick on the permanent magnet that magnetic field intensity is 0.1～0.5T.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046681.5A CN103768328A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumors |
| CN201910084673.2A CN111588789A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046681.5A CN103768328A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910084673.2A Division CN111588789A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103768328A true CN103768328A (en) | 2014-05-07 |
Family
ID=50561388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910084673.2A Pending CN111588789A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumor |
| CN201410046681.5A Pending CN103768328A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumors |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910084673.2A Pending CN111588789A (en) | 2014-02-11 | 2014-02-11 | Medicinal magnetic plaster for treating tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN111588789A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666671A (en) * | 2015-01-22 | 2015-06-03 | 林树芳 | Anti-cancer analgesic medicine of Chinese yew and preparation method of anti-cancer analgesic medicine |
| CN112773861A (en) * | 2021-02-09 | 2021-05-11 | 李华斌 | A plaster for treating pain and ulcer, and its preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171265A (en) * | 1997-06-27 | 1998-01-28 | 马国文 | Chinese-emdicinal pill for dispersing stasis |
| CN1437996A (en) * | 2003-02-28 | 2003-08-27 | 陈炳坤 | Huanyang blood-changing pill and its preparation method |
| CN101385843A (en) * | 2008-10-21 | 2009-03-18 | 刘少敏 | Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| CN101785847A (en) * | 2010-02-28 | 2010-07-28 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1122230A (en) * | 1994-11-02 | 1996-05-15 | 成都新兴中医药研究所 | Compond sansheng pills |
| CN100337652C (en) * | 2003-06-07 | 2007-09-19 | 范兴合 | Chinese medicinal decoction for preventing and treating cancer |
-
2014
- 2014-02-11 CN CN201910084673.2A patent/CN111588789A/en active Pending
- 2014-02-11 CN CN201410046681.5A patent/CN103768328A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171265A (en) * | 1997-06-27 | 1998-01-28 | 马国文 | Chinese-emdicinal pill for dispersing stasis |
| CN1437996A (en) * | 2003-02-28 | 2003-08-27 | 陈炳坤 | Huanyang blood-changing pill and its preparation method |
| CN101385843A (en) * | 2008-10-21 | 2009-03-18 | 刘少敏 | Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| CN101785847A (en) * | 2010-02-28 | 2010-07-28 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张问渠: "《现代著名老中医临床诊治荟萃》", 31 January 2003, 科学技术文献出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666671A (en) * | 2015-01-22 | 2015-06-03 | 林树芳 | Anti-cancer analgesic medicine of Chinese yew and preparation method of anti-cancer analgesic medicine |
| CN112773861A (en) * | 2021-02-09 | 2021-05-11 | 李华斌 | A plaster for treating pain and ulcer, and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111588789A (en) | 2020-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN102526635B (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN101874850B (en) | Medicament for treating chronic urticaria | |
| CN103768358B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN103768328A (en) | Medicinal magnetic plaster for treating tumors | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN105031532A (en) | Traditional Chinese medicine composition for treating seroperitoneum and preparation thereof | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104274603A (en) | Traditional Chinese medicine for treating leg cramps | |
| CN104825768A (en) | Traditional Chinese medicine oral liquid for treating scrofula and preparation method thereof | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN103520289A (en) | Chinese medicinal composition for treating constipation, preparation method and application thereof | |
| CN103656149A (en) | Preparation method of traditional Chinese medicine prescription for treating insomnia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN102784344B (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
| CN106822772A (en) | A kind of Traditional chinese medicine medicament formula for treating rheumatic arthritis | |
| CN104042728A (en) | Traditional Chinese medicine for treating rectocele | |
| CN103845402A (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN101862395A (en) | Tumor curing medicine containing saussurea involucrate and preparation method thereof | |
| CN101862433A (en) | Chinese medicament for treating psoriasis | |
| CN109954113A (en) | Anti-tumor healthcare tea and preparation method thereof | |
| CN107050205A (en) | One kind treats roseolous Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination |